Global Pharmacovigilance Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 286835
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Pharmacovigilance market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Pharmacovigilance market size is estimated to be worth US$ 4512.6 million in 2021 and is forecast to a readjusted size of USD 7610.2 million by 2028 with a CAGR of 7.8% during review period. Pharma and Biotech Companies accounting for % of the Pharmacovigilance global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Chemotherapy segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Pharmacovigilance include Eli Lilly and Company, ICON, Elsevier, Chiltern, and Atlantic Research Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Pharmacovigilance market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Chemotherapy

Contract Outsourcing

Market segment by Application, can be divided into

Pharma and Biotech Companies

Contract Research Organizations (CROs)

Business Process Outsourcing (BPO) Firms

Others

Market segment by players, this report covers

Eli Lilly and Company

ICON

Elsevier

Chiltern

Atlantic Research Group

Mapi Group

Accenture

Clinquest Group

GSK

PRA Health Sciences

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Pharmacovigilance product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Pharmacovigilance, with revenue, gross margin and global market share of Pharmacovigilance from 2019 to 2022.

Chapter 3, the Pharmacovigilance competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmacovigilance market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Pharmacovigilance research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Pharmacovigilance

1.2 Classification of Pharmacovigilance by Type

1.2.1 Overview: Global Pharmacovigilance Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Pharmacovigilance Revenue Market Share by Type in 2021

1.2.3 Chemotherapy

1.2.4 Contract Outsourcing

1.3 Global Pharmacovigilance Market by Application

1.3.1 Overview: Global Pharmacovigilance Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Pharma and Biotech Companies

1.3.3 Contract Research Organizations (CROs)

1.3.4 Business Process Outsourcing (BPO) Firms

1.3.5 Others

1.4 Global Pharmacovigilance Market Size & Forecast

1.5 Global Pharmacovigilance Market Size and Forecast by Region

1.5.1 Global Pharmacovigilance Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Pharmacovigilance Market Size by Region, (2017-2022)

1.5.3 North America Pharmacovigilance Market Size and Prospect (2017-2028)

1.5.4 Europe Pharmacovigilance Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Pharmacovigilance Market Size and Prospect (2017-2028)

1.5.6 South America Pharmacovigilance Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Pharmacovigilance Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharmacovigilance Market Drivers

1.6.2 Pharmacovigilance Market Restraints

1.6.3 Pharmacovigilance Trends Analysis

2 Company Profiles

2.1 Eli Lilly and Company

2.1.1 Eli Lilly and Company Details

2.1.2 Eli Lilly and Company Major Business

2.1.3 Eli Lilly and Company Pharmacovigilance Product and Solutions

2.1.4 Eli Lilly and Company Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Eli Lilly and Company Recent Developments and Future Plans

2.2 ICON

2.2.1 ICON Details

2.2.2 ICON Major Business

2.2.3 ICON Pharmacovigilance Product and Solutions

2.2.4 ICON Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 ICON Recent Developments and Future Plans

2.3 Elsevier

2.3.1 Elsevier Details

2.3.2 Elsevier Major Business

2.3.3 Elsevier Pharmacovigilance Product and Solutions

2.3.4 Elsevier Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Elsevier Recent Developments and Future Plans

2.4 Chiltern

2.4.1 Chiltern Details

2.4.2 Chiltern Major Business

2.4.3 Chiltern Pharmacovigilance Product and Solutions

2.4.4 Chiltern Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Chiltern Recent Developments and Future Plans

2.5 Atlantic Research Group

2.5.1 Atlantic Research Group Details

2.5.2 Atlantic Research Group Major Business

2.5.3 Atlantic Research Group Pharmacovigilance Product and Solutions

2.5.4 Atlantic Research Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Atlantic Research Group Recent Developments and Future Plans

2.6 Mapi Group

2.6.1 Mapi Group Details

2.6.2 Mapi Group Major Business

2.6.3 Mapi Group Pharmacovigilance Product and Solutions

2.6.4 Mapi Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Mapi Group Recent Developments and Future Plans

2.7 Accenture

2.7.1 Accenture Details

2.7.2 Accenture Major Business

2.7.3 Accenture Pharmacovigilance Product and Solutions

2.7.4 Accenture Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Accenture Recent Developments and Future Plans

2.8 Clinquest Group

2.8.1 Clinquest Group Details

2.8.2 Clinquest Group Major Business

2.8.3 Clinquest Group Pharmacovigilance Product and Solutions

2.8.4 Clinquest Group Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Clinquest Group Recent Developments and Future Plans

2.9 GSK

2.9.1 GSK Details

2.9.2 GSK Major Business

2.9.3 GSK Pharmacovigilance Product and Solutions

2.9.4 GSK Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 GSK Recent Developments and Future Plans

2.10 PRA Health Sciences

2.10.1 PRA Health Sciences Details

2.10.2 PRA Health Sciences Major Business

2.10.3 PRA Health Sciences Pharmacovigilance Product and Solutions

2.10.4 PRA Health Sciences Pharmacovigilance Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 PRA Health Sciences Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmacovigilance Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharmacovigilance Players Market Share in 2021

3.2.2 Top 10 Pharmacovigilance Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Pharmacovigilance Players Head Office, Products and Services Provided

3.4 Pharmacovigilance Mergers & Acquisitions

3.5 Pharmacovigilance New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pharmacovigilance Revenue and Market Share by Type (2017-2022)

4.2 Global Pharmacovigilance Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Pharmacovigilance Revenue Market Share by Application (2017-2022)

5.2 Global Pharmacovigilance Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Pharmacovigilance Revenue by Type (2017-2028)

6.2 North America Pharmacovigilance Revenue by Application (2017-2028)

6.3 North America Pharmacovigilance Market Size by Country

6.3.1 North America Pharmacovigilance Revenue by Country (2017-2028)

6.3.2 United States Pharmacovigilance Market Size and Forecast (2017-2028)

6.3.3 Canada Pharmacovigilance Market Size and Forecast (2017-2028)

6.3.4 Mexico Pharmacovigilance Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Pharmacovigilance Revenue by Type (2017-2028)

7.2 Europe Pharmacovigilance Revenue by Application (2017-2028)

7.3 Europe Pharmacovigilance Market Size by Country

7.3.1 Europe Pharmacovigilance Revenue by Country (2017-2028)

7.3.2 Germany Pharmacovigilance Market Size and Forecast (2017-2028)

7.3.3 France Pharmacovigilance Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Pharmacovigilance Market Size and Forecast (2017-2028)

7.3.5 Russia Pharmacovigilance Market Size and Forecast (2017-2028)

7.3.6 Italy Pharmacovigilance Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pharmacovigilance Revenue by Type (2017-2028)

8.2 Asia-Pacific Pharmacovigilance Revenue by Application (2017-2028)

8.3 Asia-Pacific Pharmacovigilance Market Size by Region

8.3.1 Asia-Pacific Pharmacovigilance Revenue by Region (2017-2028)

8.3.2 China Pharmacovigilance Market Size and Forecast (2017-2028)

8.3.3 Japan Pharmacovigilance Market Size and Forecast (2017-2028)

8.3.4 South Korea Pharmacovigilance Market Size and Forecast (2017-2028)

8.3.5 India Pharmacovigilance Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Pharmacovigilance Market Size and Forecast (2017-2028)

8.3.7 Australia Pharmacovigilance Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Pharmacovigilance Revenue by Type (2017-2028)

9.2 South America Pharmacovigilance Revenue by Application (2017-2028)

9.3 South America Pharmacovigilance Market Size by Country

9.3.1 South America Pharmacovigilance Revenue by Country (2017-2028)

9.3.2 Brazil Pharmacovigilance Market Size and Forecast (2017-2028)

9.3.3 Argentina Pharmacovigilance Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pharmacovigilance Revenue by Type (2017-2028)

10.2 Middle East & Africa Pharmacovigilance Revenue by Application (2017-2028)

10.3 Middle East & Africa Pharmacovigilance Market Size by Country

10.3.1 Middle East & Africa Pharmacovigilance Revenue by Country (2017-2028)

10.3.2 Turkey Pharmacovigilance Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Pharmacovigilance Market Size and Forecast (2017-2028)

10.3.4 UAE Pharmacovigilance Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharmacovigilance Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Pharmacovigilance Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Pharmacovigilance Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Pharmacovigilance Revenue (USD Million) by Region (2017-2022)

Table 5. Global Pharmacovigilance Revenue Market Share by Region (2023-2028)

Table 6. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 7. Eli Lilly and Company Major Business

Table 8. Eli Lilly and Company Pharmacovigilance Product and Solutions

Table 9. Eli Lilly and Company Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. ICON Corporate Information, Head Office, and Major Competitors

Table 11. ICON Major Business

Table 12. ICON Pharmacovigilance Product and Solutions

Table 13. ICON Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Elsevier Corporate Information, Head Office, and Major Competitors

Table 15. Elsevier Major Business

Table 16. Elsevier Pharmacovigilance Product and Solutions

Table 17. Elsevier Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Chiltern Corporate Information, Head Office, and Major Competitors

Table 19. Chiltern Major Business

Table 20. Chiltern Pharmacovigilance Product and Solutions

Table 21. Chiltern Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Atlantic Research Group Corporate Information, Head Office, and Major Competitors

Table 23. Atlantic Research Group Major Business

Table 24. Atlantic Research Group Pharmacovigilance Product and Solutions

Table 25. Atlantic Research Group Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Mapi Group Corporate Information, Head Office, and Major Competitors

Table 27. Mapi Group Major Business

Table 28. Mapi Group Pharmacovigilance Product and Solutions

Table 29. Mapi Group Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Accenture Corporate Information, Head Office, and Major Competitors

Table 31. Accenture Major Business

Table 32. Accenture Pharmacovigilance Product and Solutions

Table 33. Accenture Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Clinquest Group Corporate Information, Head Office, and Major Competitors

Table 35. Clinquest Group Major Business

Table 36. Clinquest Group Pharmacovigilance Product and Solutions

Table 37. Clinquest Group Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. GSK Corporate Information, Head Office, and Major Competitors

Table 39. GSK Major Business

Table 40. GSK Pharmacovigilance Product and Solutions

Table 41. GSK Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. PRA Health Sciences Corporate Information, Head Office, and Major Competitors

Table 43. PRA Health Sciences Major Business

Table 44. PRA Health Sciences Pharmacovigilance Product and Solutions

Table 45. PRA Health Sciences Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Pharmacovigilance Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Pharmacovigilance Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Pharmacovigilance by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Pharmacovigilance Players Head Office, Products and Services Provided

Table 50. Pharmacovigilance Mergers & Acquisitions in the Past Five Years

Table 51. Pharmacovigilance New Entrants and Expansion Plans

Table 52. Global Pharmacovigilance Revenue (USD Million) by Type (2017-2022)

Table 53. Global Pharmacovigilance Revenue Share by Type (2017-2022)

Table 54. Global Pharmacovigilance Revenue Forecast by Type (2023-2028)

Table 55. Global Pharmacovigilance Revenue by Application (2017-2022)

Table 56. Global Pharmacovigilance Revenue Forecast by Application (2023-2028)

Table 57. North America Pharmacovigilance Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Pharmacovigilance Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Pharmacovigilance Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Pharmacovigilance Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Pharmacovigilance Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Pharmacovigilance Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Pharmacovigilance Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Pharmacovigilance Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Pharmacovigilance Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Pharmacovigilance Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Pharmacovigilance Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Pharmacovigilance Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Pharmacovigilance Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Pharmacovigilance Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Pharmacovigilance Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Pharmacovigilance Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Pharmacovigilance Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Pharmacovigilance Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Pharmacovigilance Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Pharmacovigilance Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Pharmacovigilance Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Pharmacovigilance Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Pharmacovigilance Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Pharmacovigilance Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Pharmacovigilance Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Pharmacovigilance Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Pharmacovigilance Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Pharmacovigilance Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Pharmacovigilance Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Pharmacovigilance Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Pharmacovigilance Picture

Figure 2. Global Pharmacovigilance Revenue Market Share by Type in 2021

Figure 3. Chemotherapy

Figure 4. Contract Outsourcing

Figure 5. Pharmacovigilance Revenue Market Share by Application in 2021

Figure 6. Pharma and Biotech Companies Picture

Figure 7. Contract Research Organizations (CROs) Picture

Figure 8. Business Process Outsourcing (BPO) Firms Picture

Figure 9. Others Picture

Figure 10. Global Pharmacovigilance Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Pharmacovigilance Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Pharmacovigilance Revenue Market Share by Region (2017-2028)

Figure 13. Global Pharmacovigilance Revenue Market Share by Region in 2021

Figure 14. North America Pharmacovigilance Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Pharmacovigilance Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Pharmacovigilance Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Pharmacovigilance Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Pharmacovigilance Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Pharmacovigilance Market Drivers

Figure 20. Pharmacovigilance Market Restraints

Figure 21. Pharmacovigilance Market Trends

Figure 22. Eli Lilly and Company Recent Developments and Future Plans

Figure 23. ICON Recent Developments and Future Plans

Figure 24. Elsevier Recent Developments and Future Plans

Figure 25. Chiltern Recent Developments and Future Plans

Figure 26. Atlantic Research Group Recent Developments and Future Plans

Figure 27. Mapi Group Recent Developments and Future Plans

Figure 28. Accenture Recent Developments and Future Plans

Figure 29. Clinquest Group Recent Developments and Future Plans

Figure 30. GSK Recent Developments and Future Plans

Figure 31. PRA Health Sciences Recent Developments and Future Plans

Figure 32. Global Pharmacovigilance Revenue Share by Players in 2021

Figure 33. Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 34. Global Top 3 Players Pharmacovigilance Revenue Market Share in 2021

Figure 35. Global Top 10 Players Pharmacovigilance Revenue Market Share in 2021

Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 37. Global Pharmacovigilance Revenue Share by Type in 2021

Figure 38. Global Pharmacovigilance Market Share Forecast by Type (2023-2028)

Figure 39. Global Pharmacovigilance Revenue Share by Application in 2021

Figure 40. Global Pharmacovigilance Market Share Forecast by Application (2023-2028)

Figure 41. North America Pharmacovigilance Sales Market Share by Type (2017-2028)

Figure 42. North America Pharmacovigilance Sales Market Share by Application (2017-2028)

Figure 43. North America Pharmacovigilance Revenue Market Share by Country (2017-2028)

Figure 44. United States Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 45. Canada Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Mexico Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Europe Pharmacovigilance Sales Market Share by Type (2017-2028)

Figure 48. Europe Pharmacovigilance Sales Market Share by Application (2017-2028)

Figure 49. Europe Pharmacovigilance Revenue Market Share by Country (2017-2028)

Figure 50. Germany Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. France Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. United Kingdom Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. Russia Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Italy Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Asia-Pacific Pharmacovigilance Sales Market Share by Type (2017-2028)

Figure 56. Asia-Pacific Pharmacovigilance Sales Market Share by Application (2017-2028)

Figure 57. Asia-Pacific Pharmacovigilance Revenue Market Share by Region (2017-2028)

Figure 58. China Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Japan Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. South Korea Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. India Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Southeast Asia Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Australia Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South America Pharmacovigilance Sales Market Share by Type (2017-2028)

Figure 65. South America Pharmacovigilance Sales Market Share by Application (2017-2028)

Figure 66. South America Pharmacovigilance Revenue Market Share by Country (2017-2028)

Figure 67. Brazil Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Argentina Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Middle East and Africa Pharmacovigilance Sales Market Share by Type (2017-2028)

Figure 70. Middle East and Africa Pharmacovigilance Sales Market Share by Application (2017-2028)

Figure 71. Middle East and Africa Pharmacovigilance Revenue Market Share by Country (2017-2028)

Figure 72. Turkey Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Saudi Arabia Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. UAE Pharmacovigilance Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Methodology

Figure 76. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz